Phosphorylation State of RB Modulates Ferroptotic Sensitivity.

Area of Science:

• Cell biology
• Molecular oncology
• Biochemistry

Background:

• Tumor suppressor RB protein regulates cell cycle progression by binding E2F transcription factors.
• Cyclin-dependent kinases (CDKs) modulate RB/E2F interactions through RB phosphorylation.
• Previous studies indicated that CDK2, RB, and E2F inhibit ferroptosis, an iron-dependent cell death pathway.

Purpose of the Study:

• To investigate if RB is a downstream target of CDK activity in ferroptosis regulation.
• To elucidate the role of RB phosphorylation by CDKs in controlling ferroptosis.

Main Methods:

• Overexpression of wild-type (WT) RB and a CDK-non-phosphorylatable RB mutant (RBΔCDK).
• Analysis of ferroptosis sensitivity in cells expressing WT-RB or RBΔCDK.
• Assessment of CDK2's effect on ferroptosis in the presence of WT-RB and RBΔCDK.

Main Results:

• Overexpression of WT-RB decreased ferroptosis sensitivity, while RBΔCDK increased sensitivity.
• Increased CDK2 expression reduced ferroptosis sensitivity, an effect sustained in RBΔCDK-expressing cells.
• WT-RB expression abrogated CDK2's capacity to inhibit ferroptosis.

Conclusions:

• RB phosphorylation by CDKs is a key mechanism by which CDK2 inhibits ferroptosis.
• These findings identify a novel regulatory pathway involving RB and CDKs in ferroptosis control.